Skip to content

Clinical trials

Phase 1 Lung Neoplasms trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 1 Country / region: Netherlands Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20132
20152
20161
20192
20211
20222
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting2
Active, not recruiting1
Not yet recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie2
Novartis Pharmaceuticals2
Amgen1
Blueprint Medicines Corporation1
DeuterOncology1
European Organisation for Research and Treatment of Cancer - EORTC1
Incyte Corporation1
Merck KGaA, Darmstadt, Germany1
Millennium Pharmaceuticals, Inc.1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms15
Carcinoma, Non-Small-Cell Lung8
Neoplasms5
Stomach Neoplasms5
Urinary Bladder Neoplasms4
Breast Neoplasms3
Colonic Neoplasms3
Carcinoma2
Carcinoma, Renal Cell2
Head and Neck Neoplasms2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.